| Dr David R Enis, MD, PHD | |
|
2301 Huntingdon Pike, Suite 202, Huntingdon Valley, PA 19006-6130 | |
| (215) 947-7500 | |
| Not Available |
| Full Name | Dr David R Enis |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 18 Years |
| Location | 2301 Huntingdon Pike, Huntingdon Valley, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154441624 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD440165 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pennsylvania Dermatology Group Pc | 9830170877 | 9 |
News Archive
Using technical advances not yet developed when the 2014 Ebola outbreak began, UC San Francisco-led scientists completed a proof-of-principle study on a real-time blood test based on DNA sequencing that can be used to rapidly diagnose Ebola and other acute infections. The researchers said that the test can be used even where lab space and medical infrastructure are scarce.
In his first U.N. General Assembly address, President Obama on Wednesday "called for 'a new era of engagement' ... with the world, pledging to work together with other countries while defending the interests of the United States," Reuters reports (9/23).
Survival rates for patients with breast cancer have improved significantly in the last four decades, and many patients will eventually die from non-cancer-related causes.
Apicore LLC announced today that the U.S. Food and Drug Administration (FDA) completed an inspection of its API manufacturing plant in Somerset, New Jersey on July 13, 2010.
› Verified 4 days ago
| Entity Name | Pennsylvania Dermatology Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942357454 PECOS PAC ID: 9830170877 Enrollment ID: O20040526000898 |
News Archive
Using technical advances not yet developed when the 2014 Ebola outbreak began, UC San Francisco-led scientists completed a proof-of-principle study on a real-time blood test based on DNA sequencing that can be used to rapidly diagnose Ebola and other acute infections. The researchers said that the test can be used even where lab space and medical infrastructure are scarce.
In his first U.N. General Assembly address, President Obama on Wednesday "called for 'a new era of engagement' ... with the world, pledging to work together with other countries while defending the interests of the United States," Reuters reports (9/23).
Survival rates for patients with breast cancer have improved significantly in the last four decades, and many patients will eventually die from non-cancer-related causes.
Apicore LLC announced today that the U.S. Food and Drug Administration (FDA) completed an inspection of its API manufacturing plant in Somerset, New Jersey on July 13, 2010.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David R Enis, MD, PHD 2301 Huntingdon Pike, Suite 202, Huntingdon Valley, PA 19006-6130 Ph: (215) 947-7500 | Dr David R Enis, MD, PHD 2301 Huntingdon Pike, Suite 202, Huntingdon Valley, PA 19006-6130 Ph: (215) 947-7500 |
News Archive
Using technical advances not yet developed when the 2014 Ebola outbreak began, UC San Francisco-led scientists completed a proof-of-principle study on a real-time blood test based on DNA sequencing that can be used to rapidly diagnose Ebola and other acute infections. The researchers said that the test can be used even where lab space and medical infrastructure are scarce.
In his first U.N. General Assembly address, President Obama on Wednesday "called for 'a new era of engagement' ... with the world, pledging to work together with other countries while defending the interests of the United States," Reuters reports (9/23).
Survival rates for patients with breast cancer have improved significantly in the last four decades, and many patients will eventually die from non-cancer-related causes.
Apicore LLC announced today that the U.S. Food and Drug Administration (FDA) completed an inspection of its API manufacturing plant in Somerset, New Jersey on July 13, 2010.
› Verified 4 days ago
Dr. Jeffrey L Pollock, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2600 Philmont Ave Ste 309, Huntingdon Valley, PA 19006 Phone: 215-938-1700 Fax: 215-947-7546 | |
Emily E Dando, MD Dermatology Medicare: Medicare Enrolled Practice Location: 2301 Huntingdon Pike Ste 202, Huntingdon Valley, PA 19006 Phone: 215-947-7500 Fax: 215-947-7501 | |
Mr. Barry Steven Friter, MD Dermatology Medicare: Medicare Enrolled Practice Location: 2301 Huntingdon Pike, Suite 202, Huntingdon Valley, PA 19006 Phone: 215-947-7500 Fax: 215-947-7501 | |
Katherine Goldfeder Evans, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2301 Huntingdon Pike Ste 202, Huntingdon Valley, PA 19006 Phone: 215-947-7500 | |
Samuel Chachkin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2301 Huntingdon Pike, Suite 202, Huntingdon Valley, PA 19006 Phone: 215-947-7500 |